Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 5921–5940 of 17,529 recalls

January 28, 2020· NCS Healthcare of Kentucky Inc

Recalled Item: Glycopyrrolate Tabs

The Issue: Failed Impurities/Degradation Specification: High Out of Specification Results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 28, 2020· Teva Pharmaceuticals USA

Recalled Item: Tramadol Hydrochloride Tablets USP CIV

The Issue: Labeling: Incorrect package insert - Patient leaflets for

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
January 28, 2020· B AND A TRADING CORPORATION

Recalled Item: Kushim Tablets (Gushim) 45-count packages

The Issue: Marketed Without an Approved NDA/ANDA. FDA analysis found

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 28, 2020· Graviti Pharmaceuticals Private Limited

Recalled Item: Atorvastatin Calcium Tablets

The Issue: Presence of Foreign Tablets/Capsules: Customer complaint that one

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Methylphenidate hydrochloride Extended-Release ablets USP (CII)

The Issue: CGMP deviations: Product bottle may be absent of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Methylphenidate hydrochloride Extended-Release ablets USP (CII)

The Issue: CGMP deviations: Product bottle may be absent of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Desmopressin Acetate Tablets

The Issue: GMP Deviations: Product bottle may be absent of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 27, 2020· Teva Pharmaceuticals USA

Recalled Item: Desmopressin Acetate Tablets

The Issue: GMP Deviations: Product bottle may be absent of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Solifenacin Succinate Tablets

The Issue: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 24, 2020· Breckenridge Pharmaceutical, Inc

Recalled Item: Solifenacin Succinate Tablets

The Issue: CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 24, 2020· Ascend Laboratories LLC

Recalled Item: Olmesartan Medoxomil Tablets 20 mg

The Issue: cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 24, 2020· Macleods Pharma Usa Inc

Recalled Item: Pioglitazone and Metformin Hydrochloride Tablets

The Issue: Subpotent Drug: Out of specification assay result, below

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
January 22, 2020· Ascend Laboratories LLC

Recalled Item: Minocycline Hydrochloride Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
January 20, 2020· Macleods Pharma Usa Inc

Recalled Item: Montelukast Sodium Chewable Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
January 16, 2020· Shandex Personal Care Manufacturing Inc.

Recalled Item: Walgreens Acne Cleansing Bar

The Issue: Presence of Foreign Substance; Metal contaminant visible in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 15, 2020· Direct Rx

Recalled Item: Ranitidine 150 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 15, 2020· Direct Rx

Recalled Item: Ranitidine 300 mg

The Issue: CGMP Deviations: Presence of NDMA impurity detected in

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Polyoxyl Lauryl Ether (Polidocanol) Injection

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: Alprostadil/Papaverine Hydrochloride/Phentolamine Mesylate Injection...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 15, 2020· Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Recalled Item: BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund